ArticleCancer research communications2023

Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.

Benjamin J Bulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.